Yi Zhang

7PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyNeurosciences not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 16, 2026
Radiotherapy combined with serplulimab, and chemotherapy as first-line treatment for metastatic pancreatic adenocarcinoma: a multicenter, single-arm, phase II trial.

|Jan 11, 2025
Correction: Zhang et al. Hepatitis B Virus X Protein (HBx) Suppresses Transcription Factor EB (TFEB) Resulting in Stabilization of Integrin Beta 1 (ITGB1) in Hepatocellular Carcinoma Cells. Cancers 2021, 13, 1181.

Chunyan Zhang, Huan Yang, Liwei Pan

|Sep 23, 2022
Surgical Outcomes, Long-Term Survivals and Staging Systems of World Health Organization G3 Pancreatic Neuroendocrine Tumors.

Min Yang, Lin Zeng, Shengzhong Hou

|Jun 10, 2022
Surgical Outcomes and Prognostic Factors of G3 Pancreatic Neuroendocrine Carcinomas: A Consecutive Analysis Based on Previous Study Results.

Xinmei Luo, Min Yang, Bole Tian

|Nov 12, 2020
A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.

Min Yang, Lin Zeng, Wen-Qing Yao

|Oct 05, 2020
Clinical Features and Long-Term Survival of Metastatic Hepatic Neuroendocrine Neoplasms Secondary to Gastroenteropancreatic Site: An Analysis by Applying the Grading Classification.

Min Yang, Lin Zeng, Sheng-Zhong Hou

Pageof 2

Frequent Collaborators

1 joint publications

Zhixiong Xiao

1 joint publications

Ying Tong

1 joint publications

Stephen J Pandol

1 joint publications

Yuan-Ping Han